NuCana plc ROE Ratio 2011-2026 | NCNA

Annual ROE Ratio NuCana plc

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-30.92	-33.71	-16.96	-24.71	-	-	-	-	-	-

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
-16.96	-33.71	-26.58

Quarterly ROE Ratio NuCana plc

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-10.38	-20.77	-31.56	-31.85	-39.46	-36.69	-36.51	-24.78	-30.31	-28.22	-23.73	-18.63	-21.6	-19.04	-14.44	-11.8	-85.39	-156.02	-167.35	-86.45	-86.45	-12.85	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in GBP currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-10.38	-167.35	-45.19

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-21.9	-	1052.0 %	$ 415 M	USA
Veracyte VCYT	5.07	$ 30.92	-5.73 %	$ 2.43 B	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	-36.89	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	-294.78	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	-91.56	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-418.16	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
Atreca BCEL	-123.92	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-108.93	-	-	$ 546 M	USA
Acasti Pharma ACST	-14.36	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Avid Bioservices CDMO	-231.16	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	156.54	-	2.71 %	$ 14 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	-27.19	$ 12.67	-9.24 %	$ 1.92 B	USA
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
Alnylam Pharmaceuticals ALNY	39.76	$ 321.51	-2.03 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	45.18	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-207.61	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-46.05	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	-63.65	$ 1.09	-	$ 22.4 M	Israel
Enochian Biosciences ENOB	833.76	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Equillium EQ	-78.32	$ 1.91	-7.28 %	$ 109 M	USA
Amphastar Pharmaceuticals AMPH	12.44	$ 19.46	-0.36 %	$ 910 M	USA
Amarin Corporation plc AMRN	-8.45	$ 14.23	-2.97 %	$ 5.91 B	Irlanda
Bellerophon Therapeutics BLPH	-782.6	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	-30.26	$ 45.99	-3.28 %	$ 4.14 B	Schweiz
Arbutus Biopharma Corporation ABUS	-43.75	$ 4.33	-2.81 %	$ 830 M	Canada
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-57.34	-	-5.38 %	$ 6.06 M	USA
Freeline Therapeutics Holdings plc FRLN	-169.75	-	-	$ 384 M	Britain
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA